DNMT3B antibody (AA 389-417)
Quick Overview for DNMT3B antibody (AA 389-417) (ABIN3030752)
Target
See all DNMT3B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 389-417
-
Purpose
- Dnmt3b Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 389-417 from the human protein was used as the immunogen for this Dnmt3b antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the Dnmt3b antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the Dnmt3b antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- DNMT3B (DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B))
-
Alternative Name
- Dnmt3b
-
Background
- CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. Dnmt3b is a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF)syndrome.
-
UniProt
- Q9UBC3
Target
-